TriVascular Technologies says it plans to price the shares at $13 to $15 in its initial public offering, which could raise as much as $97.5 million.
TriVascular Technologies said it could raise as much as $98 million from its planned initial public offering after setting the per-share price range at $13-$15.
That would set the top end of the 6.5-million-share offering at $97.5 million, or $84.5 million at the low end.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oy4lt9
Cap comentari:
Publica un comentari a l'entrada